Logo

PINC

Premier, Inc.

PINC

Premier, Inc. NASDAQ
$28.26 0.32% (+0.09)

Market Cap $2.34 B
52w High $28.79
52w Low $17.23
Dividend Yield 0.63%
P/E 166.24
Volume 2.06M
Outstanding Shares 82.63M

Income Statement

Period Revenue Operating Expense Net Income Net Profit Margin Earnings Per Share EBITDA
Q1-2026 $240.004M $145.713M $17.579M 7.324% $0.21 $53.083M
Q4-2025 $261.382M $159.409M $27.068M 10.356% $0.31 $75.729M
Q3-2025 $261.382M $159.409M $27.068M 10.356% $0.31 $75.729M
Q2-2025 $240.266M $264.031M $-96.018M -39.963% $-1.01 $-63.284M
Q1-2025 $248.142M $145.103M $70.784M 28.526% $0.71 $64.603M

Balance Statement

Period Cash & Short-term Total Assets Total Liabilities Total Equity
Q1-2026 $43.38M $3.051B $1.523B $1.528B
Q4-2025 $83.725M $3.097B $1.566B $1.531B
Q3-2025 $71.327M $3.072B $1.549B $1.523B
Q2-2025 $85.85M $3.142B $1.424B $1.718B
Q1-2025 $86.956M $3.314B $1.359B $1.954B

Cash Flow Statement

Period Net Income Cash From Operations Cash From Investing Cash From Financing Net Change Free Cash Flow
Q1-2026 $17.579M $15.93M $-19.504M $-36.674M $-40.345M $-3.574M
Q4-2025 $18.572M $107.985M $-61.6M $-34.012M $12.398M $86.233M
Q3-2025 $-14.151M $114.129M $-618K $-128.032M $-14.523M $93.109M
Q2-2025 $-45.837M $111.668M $-22.159M $-90.549M $-1.106M $89.509M
Q1-2025 $72.388M $67.647M $-17.718M $-88.14M $-38.19M $49.929M

Revenue by Products

Product Q2-2025Q3-2025Q4-2025Q1-2026
Administrative Fees
Administrative Fees
$130.00M $140.00M $150.00M $130.00M

Five-Year Company Overview

Income Statement

Income Statement Revenue has drifted down over the last several years, which is a key concern for a company that once showed stronger growth. Gross profit has held up better than sales, suggesting the mix is shifting toward higher‑value, data and technology services, but that has not been enough to protect profitability. Operating profit has been squeezed to around breakeven recently, and net income has dropped sharply compared with earlier years. Overall, earnings power looks much weaker than it used to be, and the business feels more like a stable utility to its members than a strong profit engine at the moment.


Balance Sheet

Balance Sheet The balance sheet looks generally solid but not particularly flush. Total assets have stayed fairly steady over time, indicating limited large‑scale expansion or acquisitions. Debt is moderate and has trended lower over the longer span, with equity comfortably above debt, which points to a conservative capital structure. However, the cash balance is relatively small, so the company does not have a huge cushion of liquidity, even though it is not heavily leveraged. Book equity has slipped from its peak, hinting at a mix of lower profits and potential capital returns to shareholders in prior years.


Cash Flow

Cash Flow Cash generation is a bright spot. Operating cash flow has been consistently healthy and more stable than reported earnings, which suggests the underlying business still throws off reliable cash despite weaker profits on paper. Free cash flow has been positive every year shown, with only modest spending needs for capital investments. This is a relatively light, software‑ and services‑driven model that does not require heavy physical assets. That steady cash flow base helps support debt obligations and strategic investments, even if reported earnings remain under pressure.


Competitive Edge

Competitive Edge Premier operates in a specialized corner of healthcare where scale, data, and relationships matter a lot. Its group purchasing organization ties together thousands of hospitals and providers, giving it strong negotiating leverage with suppliers and making its network difficult to replicate. The PINC AI platform sits on top of one of the richer healthcare datasets in the market, which feeds advanced analytics and creates meaningful switching costs for customers that have deeply integrated these tools into their workflows. This combination of network effects, proprietary data, and embedded software gives Premier a durable moat, though it still faces ongoing competition from other healthcare IT, analytics, and supply‑chain players and must constantly prove its value to cost‑pressed hospitals.


Innovation and R&D

Innovation and R&D Innovation is centered on the PINC AI suite, which uses a very large, long‑running healthcare dataset to power predictive analytics, clinical decision support, and supply‑chain optimization. Rather than traditional lab R&D, Premier’s innovation is mostly software, data science, and partnerships with life sciences and research organizations to generate real‑world evidence. The upcoming move into private ownership by Patient Square Capital is explicitly framed as a way to accelerate technology investments and sharpen focus on core data, AI, and supply‑chain solutions. The opportunity is to deepen automation, prediction, and workflow integration for hospitals; the risk is execution—ensuring that faster innovation translates into tangible improvements for customers without disrupting existing relationships.


Summary

Premier today is a financially stable but slower‑growing company with pressured profits, supported by a respectable balance sheet and dependable cash flow. Its real strength lies in its entrenched position in healthcare supply chains and its large, data‑rich analytics platform, which together create meaningful barriers to entry. The pending transition to private ownership is a strategic turning point: it could enable heavier, longer‑term investment in AI and data‑driven offerings, but also introduces uncertainty around how aggressively the new owners will push for growth and margin expansion. Going forward, the important themes to monitor are whether Premier can stabilize or re‑ignite revenue, rebuild profitability, and successfully convert its data and AI capabilities into stronger, more visible value for its hospital and provider customers.